60
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]

Pages 5751-5752 | Published online: 24 Jul 2019
 
This article refers to:
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors